GO
Loading...

PDL BioPharma Inc

More

  • Lightning Round: Sodastream, Amazon & more Wednesday, 21 May 2014 | 6:51 PM ET

    It's time for the Lightning Round. Cramer makes the call on viewer favorites.

  • Lightning Round: Berkshire Hathaway, Ford & More Wednesday, 15 May 2013 | 6:58 PM ET

    It’s time for the Lightning Round. Cramer makes the call on viewer favorites.

  • Lightning Round: AOL, Pinnacle Foods & More Tuesday, 14 May 2013 | 6:37 PM ET

    It’s time for the Lightning Round. Cramer makes the call on viewer favorites.

  • When the market is weak, there's nothing more comforting than dividend-paying stocks, Paul Hickey of Bespoke Investment Group told CNBC Monday.

  • Is a 10.6% Dividend Yield Reason To Own This Stock? Tuesday, 8 Mar 2011 | 9:08 PM ET

    Cramer weighs in on a high-yielding biotech name. Plus, his calls on Koninklijke Philips Electronics, PetSmart and more.

  • Cramer makes the call on viewers' favorite stocks.

  • 9 'Left for Dead' Stocks with Analysts’ Approval Monday, 11 Oct 2010 | 6:22 PM ET

    Here are 9 dirt-cheap stocks that analysts gave positive reviews, in part because they're so cheap. Some are predicted to double or triple in the next year. They're ordered by forward earnings multiple, from cheap to cheapest.  ...A report from TheStreet.

  • What Are Big Money Managers Doing? Thursday, 13 Aug 2009 | 7:10 PM ET

    Big money managers can instill confidence in individual stocks and you may be able to profit off their moves. Karen Finerman breaks down the holdings of the major money managers.

  • Pops & Drops: First Solar, American Express... Tuesday, 3 Mar 2009 | 6:12 PM ET

    Following are the day’s biggest winners and losers. Find out why shares of First Solar and American Express popped while Target and MetLife dropped.

  • Abbott's Covering The Bases Thursday, 14 Aug 2008 | 1:28 PM ET

    The market cap of Dow component Johnson & Johnson is a whopping $200 billion. Abbott Labs is valued at less than half that. But think of ABT as kind of a mini-me JNJ because like Johnson & Johnson, ABT has cobbled together a similar three-siloed business of drugs, devices and consumer products.

  • Pops & Drops: Halliburton, American Airlines... Friday, 11 Apr 2008 | 6:39 PM ET

    Following are the week’s biggest winners and losers. Find out why shares of Halliburton and Bank of New York Mellon popped while American Airlines and The Gap dropped.

  • DNA's Test Thursday, 10 Jan 2008 | 7:21 PM ET

    Genentech kicks off biotech earnings season Monday after the bell. Will higher sales of Avastin and Herceptin drive shares?

  • Biogen Idec: First Of A Biotech Buying Binge? Monday, 15 Oct 2007 | 12:52 PM ET

    For quite some time now analysts and investors have been speculating that big pharma would go on a biotech buying binge. So, will the announcement by Biogen Idec late Friday that it's putting itself on the market be the spark that ignites an M & A explosion in the sector? Perhaps.

  • Your First Move For Wednesday Oct. 3rd Wednesday, 3 Oct 2007 | 11:12 AM ET

    Here's our Fast Money Final Trade. Our gang gives you tomorrow's best trades, right now!

  • Stop Trading! Monday, 20 Aug 2007 | 3:33 PM ET

    Is Countrywide too big to fail? Also, Cramer's take on Lamar Advertising and PDL BioPharma.Investing can be confusing. Luckily, Cramer has mapped out some road rules for all you Home Gamers trying to navigate the jungle that is Wall Street. Think of it as "Mad Money 101" –- some fundamental advice to keep in mind as you play the market. Whether you're a first time investor or a seasoned financier, it's always good to remember the basics.

  • Game Plan for the Week of June 4 Friday, 1 Jun 2007 | 6:57 PM ET

    Next week is conference week and that means companies should have big news for investors. Here’s how to play it.Investing can be confusing. Luckily, Cramer has mapped out some road rules for all you Home Gamers trying to navigate the jungle that is Wall Street. Think of it as "Mad Money 101" –- some fundamental advice to keep in mind as you play the market. Whether you're a first time investor or a seasoned financier, it's always good to remember the basics.

  • Trading With Stars: Nothing To Do But Wait! Friday, 11 May 2007 | 12:54 PM ET

    Friday--today--is the last day of Trading With The Stars--and only transactions that were input by 4 pm ET Thursday will make a difference in their standings.  As the Dow fell almost 150 points, Ernie Hudson was the only celeb to show a portfolio gain Thursday--on Gmarket. Jonathan Tucker regained the top spot, and Stephen Collins fell back into second on heavy losses in Golden Telecom.  Meanwhile, Chris Moneymaker got crushed on Allscripts Healthcare, which has cost him $181,862.60 since he purchased it on 5/8, and he is now in last place. James Cromwell was hit hard by Knot Inc. which cost him $160K dropping him from 4th to 8th.

  • Celebs "Acting Up A Storm" In Last Days Of Trades Wednesday, 9 May 2007 | 11:31 AM ET

    The top 4 celebrities remain constant with Jonathan Tucker holding onto his lead with only $62,581.29 separating him from Stephen Collins. Poker champion Moneymaker is betting on Allscripts Healthcare to move him up from 4th on strong earnings after the bell Tuesday. And Hall of Famer Johnny Bench is counting on American Oriental Bioengineering to continue to perform--as he's in 5th place.

  • Sudden Death Tuesday, 17 Apr 2007 | 6:57 PM ET

    PDL BioPharma, United Online, Vertex Pharma: In under a minute, Cramer's got calls on all three.Investing can be confusing. Luckily, Cramer has mapped out some road rules for all you Home Gamers trying to navigate the jungle that is Wall Street. Think of it as "Mad Money 101" –- some fundamental advice to keep in mind as you play the market. Whether you're a first time investor or a seasoned financier, it's always good to remember the basics.

  • Poor Management + Activist = $$$ Monday, 26 Mar 2007 | 6:51 PM ET

    Take a company that’s being managed into the ground, add an activist investor to stir things up, and you’ve got a stock that should go higher. Tonight, Cramer’s got a play that fits the model.Investing can be confusing. Luckily, Cramer has mapped out some road rules for all you Home Gamers trying to navigate the jungle that is Wall Street. Think of it as "Mad Money 101" –- some fundamental advice to keep in mind as you play the market. Whether you're a first time investor or a seasoned financier, it's always good to remember the basics.